What will be the impact of drug-eluting stents on hybrid coronary revascularization?
Karamanoukian
Hratch L
HL
D019917:Blood Vessel Prosthesis Implantation; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D009204:Myocardial Revascularization; D020123:Sirolimus / Q000008:administration & dosage* / Q000627:therapeutic use*; D015607:Stents
D007166:Immunosuppressive Agents; D020123:Sirolimus